Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies
![Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies](https://www.ohe.org/wp-content/uploads/2020/06/Simon-Cover-150x150.png)
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.